{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:42:27Z","timestamp":1791999747168,"version":"4.4.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40266-024-01151-8","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:00:07Z","timestamp":1730091607000},"page":"959-976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Pharmacological Pain Treatment in Older Persons"],"prefix":"10.1007","volume":"41","author":[{"given":"Gis\u00e8le","family":"Pickering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Kotli\u0144ska-Lemieszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevenka","family":"Krcevski Skvarc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"O\u2019Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiammetta","family":"Monacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Knaggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kocot-K\u0119pska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,27]]},"reference":[{"key":"1151_CR1","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1532-5415.2004.52251.x","volume":"52","author":"AB Won","year":"2004","unstructured":"Won AB, Lapane KL, Vallow S, Schein J, Morris JN, Lipsitz LA. Persistent nonmalignant pain and analgesic prescribing patterns in elderly nursing home residents. J Am Geriatr Soc. 2004;52:867\u201374.","journal-title":"J Am Geriatr Soc"},{"key":"1151_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.mcna.2020.05.002","volume":"104","author":"TP Welsh","year":"2020","unstructured":"Welsh TP, Yang AE, Makris UE. Musculoskeletal pain in older adults: a clinical review. Med Clin North Am. 2020;104:855\u201372.","journal-title":"Med Clin North Am"},{"key":"1151_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1177\/0898264320931665","volume":"32","author":"Z Zimmer","year":"2020","unstructured":"Zimmer Z, Zajacova A, Grol-Prokopczyk H. Trends in pain prevalence among adults aged 50 and older across Europe, 2004 to 2015. J Aging Health. 2020;32:1419\u201332.","journal-title":"J Aging Health"},{"key":"1151_CR4","unstructured":"Lussier D, Pickering G. Pharmacological considerations in older patients in Pharmacology of pain. IASP. 2017."},{"key":"1151_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.5694\/j.1326-5377.2011.tb03107.x","volume":"194","author":"JA Lowthian","year":"2011","unstructured":"Lowthian JA, Jolley DJ, Curtis AJ, Currell A, Cameron PA, Stoelwinder JU, et al. The challenges of population ageing: accelerating demand for emergency ambulance services by older patients, 1995\u20132015. Med J Aust. 2011;194:574\u20138.","journal-title":"Med J Aust"},{"key":"1151_CR6","first-page":"655","volume":"17","author":"F Moustafa","year":"2017","unstructured":"Moustafa F, Macian N, Giron F, Schmidt J, Pereira B, Pickering G. Intervention study with Algoplus\u00ae: a pain behavioral scale for older patients in the emergency department. Pain Pract Off J World Inst Pain. 2017;17:655\u201362.","journal-title":"Pain Pract Off J World Inst Pain."},{"key":"1151_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h532","volume":"350","author":"MC Reid","year":"2015","unstructured":"Reid MC, Eccleston C, Pillemer K. Management of chronic pain in older adults. BMJ. 2015;350: h532.","journal-title":"BMJ"},{"key":"1151_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40266-021-00888-w","volume":"38","author":"TE Lehti","year":"2021","unstructured":"Lehti TE, Rinkinen M-O, Aalto U, Roitto HM, Knuutila M, \u00d6hman H, et al. Prevalence of musculoskeletal pain and analgesic treatment among community-dwelling older adults: changes from 1999 to 2019. Drugs Aging. 2021;38:931\u20137.","journal-title":"Drugs Aging"},{"key":"1151_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3514","volume":"342","author":"B Guthrie","year":"2011","unstructured":"Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011;342: d3514.","journal-title":"BMJ"},{"key":"1151_CR10","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/jocn.15595","volume":"30","author":"H-F Hsu","year":"2021","unstructured":"Hsu H-F, Chen K-M, Belcastro F, Chen Y-F. Polypharmacy and pattern of medication use in community-dwelling older adults: a systematic review. J Clin Nurs. 2021;30:918\u201328.","journal-title":"J Clin Nurs"},{"key":"1151_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40266-019-00742-0","volume":"37","author":"AA Al-Qurain","year":"2020","unstructured":"Al-Qurain AA, Gebremichael LG, Khan MS, Williams DB, Mackenzie L, Phillips C, et al. Prevalence and factors associated with analgesic prescribing in poly-medicated elderly patients. Drugs Aging. 2020;37:291\u2013300.","journal-title":"Drugs Aging"},{"key":"1151_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40266-016-0389-7","volume":"33","author":"G Pickering","year":"2016","unstructured":"Pickering G, Marcoux M, Chapiro S, David L, Rat P, Michel M, et al. An algorithm for neuropathic pain management in older people. Drugs Aging. 2016;33:575\u201383.","journal-title":"Drugs Aging"},{"key":"1151_CR13","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society 2009. Panel on pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57:1331\u201346.","DOI":"10.1111\/j.1532-5415.2009.02376.x"},{"issue":"67","key":"1151_CR14","first-page":"674","volume":"2019","author":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society","year":"2019","unstructured":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society. Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;2019(67):674\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 1","key":"1151_CR15","first-page":"i1","volume":"42","author":"A Abdulla","year":"2013","unstructured":"Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D, et al. Guidance on the management of pain in older people. Age Ageing. 2013;42(Suppl 1):i1-57.","journal-title":"Age Ageing"},{"key":"1151_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5770\/cgj.23.420","volume":"23","author":"LM Rieb","year":"2020","unstructured":"Rieb LM, Samaan Z, Furlan AD, Rabheru K, Feldman S, Hung L, et al. Canadian guidelines on opioid use disorder among older adults. Can Geriatr J CGJ. 2020;23:123\u201334.","journal-title":"Can Geriatr J CGJ."},{"key":"1151_CR17","first-page":"74","volume":"11","author":"A Bernetti","year":"2021","unstructured":"Bernetti A, Agostini F, de Sire A, Mangone M, Tognolo L, Di Cesare A, et al. Neuropathic pain and rehabilitation: a systematic review of international guidelines. Diagn Basel Switz. 2021;11:74.","journal-title":"Diagn Basel Switz."},{"key":"1151_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/ageing\/afu072","volume":"43","author":"FC Veal","year":"2014","unstructured":"Veal FC, Bereznicki LR, Thompson AJ, Peterson GM. Pharmacological management of pain in Australian Aged Care Facilities. Age Age. 2014;43:851\u20136.","journal-title":"Age Age"},{"key":"1151_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2217\/pmt-2019-0057","volume":"10","author":"M Hagen","year":"2020","unstructured":"Hagen M, Alchin J. Nonprescription drugs recommended in guidelines for common pain conditions. Pain Manag. 2020;10:117\u201329.","journal-title":"Pain Manag"},{"key":"1151_CR20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.2014.9405","volume":"312","author":"UE Makris","year":"2014","unstructured":"Makris UE, Abrams RC, Gurland B, Reid MC. Management of persistent pain in the older patient: a clinical review. JAMA. 2014;312:825\u201336.","journal-title":"JAMA"},{"key":"1151_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1741-6612.2007.00266.x","volume":"27","author":"R McConigley","year":"2008","unstructured":"McConigley R, Toye C, Goucke R, Kristjanson LJ. Developing recommendations for implementing the Australian Pain Society\u2019s pain management strategies in residential aged care. Austral J Ageing. 2008;27:45\u20139.","journal-title":"Austral J Ageing"},{"key":"1151_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.16839","volume":"3","author":"Y Han","year":"2020","unstructured":"Han Y, Balkrishnan R, Hirth RA, Hutton DW, He K, Steffick DE, et al. Assessment of prescription analgesic use in older adults with and without chronic kidney disease and outcomes. JAMA Netw Open. 2020;3: e2016839.","journal-title":"JAMA Netw Open"},{"key":"1151_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/ageing\/afx166","volume":"47","author":"SG Parker","year":"2018","unstructured":"Parker SG, McCue P, Phelps K, McCleod A, Arora S, Nockels K, et al. What is comprehensive geriatric assessment (CGA)? An umbrella review. Age Ageing. 2018;47:149\u201355.","journal-title":"Age Ageing"},{"key":"1151_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40520-019-01183-w","volume":"32","author":"JW Garrard","year":"2020","unstructured":"Garrard JW, Cox NJ, Dodds RM, Roberts HC, Sayer AA. Comprehensive geriatric assessment in primary care: a systematic review. Aging Clin Exp Res. 2020;32:197\u2013205.","journal-title":"Aging Clin Exp Res"},{"key":"1151_CR25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1","volume":"59","author":"V Ventafridda","year":"1987","unstructured":"Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59:850\u20136.","journal-title":"Cancer"},{"key":"1151_CR26","first-page":"204946372097615","volume":"16","author":"M Dunham","year":"2020","unstructured":"Dunham M, Schofield P, Knaggs R. Evidence-based clinical practice guidelines on the management of pain in older people\u2014a summary report. Br J Pain. 2020;16:204946372097615.","journal-title":"Br J Pain"},{"key":"1151_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","volume":"160","author":"J Scholz","year":"2019","unstructured":"Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019;160:53\u20139.","journal-title":"Pain"},{"key":"1151_CR28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jpainsymman.2007.12.024","volume":"37","author":"S Mercadante","year":"2009","unstructured":"Mercadante S, Ferrera P, Villari P, Casuccio A, Intravaia G, Mangione S. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage. 2009;37:632\u201341.","journal-title":"J Pain Symptom Manage"},{"key":"1151_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jpainsymman.2007.03.014","volume":"35","author":"A Paris","year":"2008","unstructured":"Paris A, Horvath R, Basset P, Thiery S, Couturier P, Franco A, et al. Nitrous oxide-oxygen mixture during care of bedsores and painful ulcers in the elderly: a randomized, crossover, open-label pilot study. J Pain Symptom Manage. 2008;35:171\u20136.","journal-title":"J Pain Symptom Manage"},{"key":"1151_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40266-018-0559-x","volume":"35","author":"P Mian","year":"2018","unstructured":"Mian P, Allegaert K, Spriet I, Tibboel D, Petrovic M. Paracetamol in older people: towards evidence-based dosing? Drugs Aging. 2018;35:603\u201324.","journal-title":"Drugs Aging"},{"key":"1151_CR31","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.3390\/jcm10153420","volume":"10","author":"U Freo","year":"2021","unstructured":"Freo U, Ruocco C, Valerio A, Scagnol I, Nisoli E. Paracetamol: a review of guideline recommendations. J Clin Med. 2021;10:3420.","journal-title":"J Clin Med"},{"key":"1151_CR32","doi-asserted-by":"crossref","unstructured":"Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006;2006:CD004257.","DOI":"10.1002\/14651858.CD004257.pub2"},{"key":"1151_CR33","doi-asserted-by":"crossref","unstructured":"Saragiotto BT, Machado GC, Ferreira ML, Pinheiro MB, Abdel Shaheed C, Maher CG. Paracetamol for low back pain. Cochrane Database Syst Rev. 2016;2016:CD012230.","DOI":"10.1002\/14651858.CD012230"},{"key":"1151_CR34","doi-asserted-by":"crossref","unstructured":"Leopoldino AO, Machado GC, Ferreira PH, Pinheiro MB, Day R, McLachlan AJ, et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev. 2019;2:CD013273.","DOI":"10.1002\/14651858.CD013273"},{"key":"1151_CR35","doi-asserted-by":"crossref","unstructured":"Wiffen PJ, Derry S, Moore RA, McNicol ED, Bell RF, Carr DB, et al. Oral paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst Rev. 2017;7:CD012637.","DOI":"10.1002\/14651858.CD012637"},{"key":"1151_CR36","doi-asserted-by":"crossref","unstructured":"Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin C-WC, Day RO, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225.","DOI":"10.1136\/bmj.h1225"},{"key":"1151_CR37","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/annrheumdis-2014-206914","volume":"75","author":"E Roberts","year":"2016","unstructured":"Roberts E, Delgado Nunes V, Buckner S, Latchem S, Constanti M, Miller P, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75:552\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1151_CR38","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1111\/bcp.13656","volume":"84","author":"JC McCrae","year":"2018","unstructured":"McCrae JC, Morrison EE, MacIntyre IM, Dear JW, Webb DJ. Long-term adverse effects of paracetamol\u2014a review. Br J Clin Pharmacol. 2018;84:2218\u201330.","journal-title":"Br J Clin Pharmacol"},{"key":"1151_CR39","doi-asserted-by":"crossref","unstructured":"McNicol ED, Ferguson MC, Haroutounian S, Carr DB, Schumann R. Single dose intravenous paracetamol or intravenous propacetamol for postoperative pain. Cochrane Database Syst Rev. 2016;2016:CD007126.","DOI":"10.1002\/14651858.CD007126.pub3"},{"key":"1151_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/SPC.0b013e32835242d2","volume":"6","author":"G Pickering","year":"2012","unstructured":"Pickering G. Analgesic use in the older person. Curr Opin Support Palliat Care. 2012;6:207\u201312.","journal-title":"Curr Opin Support Palliat Care"},{"key":"1151_CR41","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0140-6736(07)60229-3","volume":"369","author":"SR Ahmad","year":"2007","unstructured":"Ahmad SR. Safety of recommended doses of paracetamol. Lancet Lond Engl. 2007;369:462\u20133.","journal-title":"Lancet Lond Engl."},{"key":"1151_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11357-011-9218-4","volume":"34","author":"E Pujos-Guillot","year":"2012","unstructured":"Pujos-Guillot E, Pickering G, Lyan B, Ducheix G, Brandolini-Bunlon M, Glomot F, et al. Therapeutic paracetamol treatment in older persons induces dietary and metabolic modifications related to sulfur amino acids. Age Dordr Neth. 2012;34:181\u201393.","journal-title":"Age Dordr Neth."},{"key":"1151_CR43","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/hep.31678","volume":"73","author":"A Louvet","year":"2021","unstructured":"Louvet A, Ntandja Wandji LC, Lema\u00eetre E, Khaldi M, Lafforgue C, Artru F, et al. Acute liver injury with therapeutic doses of acetaminophen: a prospective study. Hepatol Baltim Md. 2021;73:1945\u201355.","journal-title":"Hepatol Baltim Md."},{"key":"1151_CR44","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1592\/phco.27.5.675","volume":"27","author":"D Parra","year":"2007","unstructured":"Parra D, Beckey NP, Stevens GR. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy. Pharmacotherapy. 2007;27:675\u201383.","journal-title":"Pharmacotherapy"},{"key":"1151_CR45","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1345\/aph.1L528","volume":"43","author":"AM Weise","year":"2009","unstructured":"Weise AM, Liu CY, Shields AF. Fatal liver failure in a patient on acetaminophen treated with sunitinib malate and levothyroxine. Ann Pharmacother. 2009;43:761\u20136.","journal-title":"Ann Pharmacother"},{"key":"1151_CR46","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.3748\/wjg.v13.i48.6608","volume":"13","author":"E Ridruejo","year":"2007","unstructured":"Ridruejo E, Cacchione R, Villamil AG, Marciano S, Gadano AC, Mand\u00f3 OG. Imatinib-induced fatal acute liver failure. World J Gastroenterol. 2007;13:6608\u20136111.","journal-title":"World J Gastroenterol"},{"key":"1151_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.23876\/j.krcp.19.106","volume":"39","author":"S Kanchanasurakit","year":"2020","unstructured":"Kanchanasurakit S, Arsu A, Siriplabpla W, Duangjai A, Saokaew S. Acetaminophen use and risk of renal impairment: a systematic review and meta-analysis. Kidney Res Clin Pract. 2020;39:81\u201392.","journal-title":"Kidney Res Clin Pract."},{"key":"1151_CR48","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/anae.13517","volume":"71","author":"F Hanks","year":"2016","unstructured":"Hanks F, McKenzie C. Paracetamol in intensive care - intravenous, oral or not at all? Anaesthesia. 2016;71:1136\u201340.","journal-title":"Anaesthesia"},{"key":"1151_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12877-015-0056-6","volume":"15","author":"KTM Rodger","year":"2015","unstructured":"Rodger KTM, Greasley-Adams C, Hodge Z, Reynish E. Expert opinion on the management of pain in hospitalised older patients with cognitive impairment: a mixed methods analysis of a national survey. BMC Geriatr. 2015;15:56.","journal-title":"BMC Geriatr"},{"key":"1151_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40266-012-0047-7","volume":"30","author":"E Falzone","year":"2013","unstructured":"Falzone E, Hoffmann C, Keita H. Postoperative analgesia in elderly patients. Drugs Aging. 2013;30:81\u201390.","journal-title":"Drugs Aging"},{"key":"1151_CR51","doi-asserted-by":"crossref","unstructured":"Hearn L, Derry S, Moore RA. Single dose dipyrone (metamizole) for acute postoperative pain in adults. Cochrane Database Syst Rev. 2016;4:CD011421.","DOI":"10.1002\/14651858.CD011421.pub2"},{"key":"1151_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0269216316655746","volume":"31","author":"J Gaertner","year":"2017","unstructured":"Gaertner J, Stamer UM, Remi C, Voltz R, Bausewein C, Sabatowski R, et al. Metamizole\/dipyrone for the relief of cancer pain: A systematic review and evidence-based recommendations for clinical practice. Palliat Med. 2017;31:26\u201334.","journal-title":"Palliat Med"},{"key":"1151_CR53","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/bja\/85.2.217","volume":"85","author":"A Montes","year":"2000","unstructured":"Montes A, Warner W, Puig MM. Use of intravenous patient-controlled analgesia for the documentation of synergy between tramadol and metamizol. Br J Anaesth. 2000;85:217\u201323.","journal-title":"Br J Anaesth"},{"key":"1151_CR54","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1023\/A:1021896622089","volume":"22","author":"H Vanegas","year":"2002","unstructured":"Vanegas H, Tortorici V. Opioidergic effects of nonopioid analgesics on the central nervous system. Cell Mol Neurobiol. 2002;22:655\u201361.","journal-title":"Cell Mol Neurobiol"},{"key":"1151_CR55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1460-9568.2007.05280.x","volume":"25","author":"E Vazquez","year":"2007","unstructured":"Vazquez E, Escobar W, Ramirez K, Vanegas H. A nonopioid analgesic acts upon the PAG-RVM axis to reverse inflammatory hyperalgesia. Eur J Neurosci. 2007;25:471\u20139.","journal-title":"Eur J Neurosci"},{"key":"1151_CR56","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/sj.bjp.0707239","volume":"151","author":"SC Pierre","year":"2007","unstructured":"Pierre SC, Schmidt R, Brenneis C, Michaelis M, Geisslinger G, Scholich K. Inhibition of cyclooxygenases by dipyrone. Br J Pharmacol. 2007;151:494\u2013503.","journal-title":"Br J Pharmacol"},{"key":"1151_CR57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bmc.2011.11.028","volume":"20","author":"T Rogosch","year":"2012","unstructured":"Rogosch T, Sinning C, Podlewski A, Watzer B, Schlosburg J, Lichtman AH, et al. Novel bioactive metabolites of dipyrone (metamizol). Bioorg Med Chem. 2012;20:101\u20137.","journal-title":"Bioorg Med Chem"},{"key":"1151_CR58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pbb.2018.09.008","volume":"175","author":"R Zajaczkowska","year":"2018","unstructured":"Zajaczkowska R, Popiolek-Barczyk K, Pilat D, Rojewska E, Makuch W, Wordliczek J, et al. Involvement of microglial cells in the antinociceptive effects of metamizol in a mouse model of neuropathic pain. Pharmacol Biochem Behav. 2018;175:77\u201388.","journal-title":"Pharmacol Biochem Behav"},{"key":"1151_CR59","unstructured":"EMA. EMA recommends aligning doses of metamizole medicines and their use during pregnancy and breastfeeding [Internet]. 2019 Mar. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/metamizole-article-31-referral-ema-recommends-aligning-doses-metamizole-medicines-and-their-use-during-pregnancy-and-breastfeeding_en.pdf."},{"key":"1151_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122918","volume":"10","author":"T K\u00f6tter","year":"2015","unstructured":"K\u00f6tter T, da Costa BR, F\u00e4ssler M, Blozik E, Linde K, J\u00fcni P, et al. Metamizole-associated adverse events: a systematic review and meta-analysis. PLoS ONE. 2015;10: e0122918.","journal-title":"PLoS ONE"},{"key":"1151_CR61","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/jcph.1512","volume":"59","author":"M Lutz","year":"2019","unstructured":"Lutz M. Metamizole (dipyrone) and the liver: a review of the literature. J Clin Pharmacol. 2019;59:1433\u201342.","journal-title":"J Clin Pharmacol"},{"key":"1151_CR62","doi-asserted-by":"crossref","unstructured":"de Oliveira LM, Diel J do AC, Nunes A, da Silva Dal Pizzol T. Prevalence of drug interactions in hospitalised elderly patients: a systematic review. Eur J Hosp Pharm Sci Pract. 2021;28:4\u20139.","DOI":"10.1136\/ejhpharm-2019-002111"},{"key":"1151_CR63","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF00558078","volume":"36","author":"E Zylber-Katz","year":"1989","unstructured":"Zylber-Katz E, Granit L, Stessman J, Levy M. Effect of age on the pharmacokinetics of dipyrone. Eur J Clin Pharmacol. 1989;36:513\u20136.","journal-title":"Eur J Clin Pharmacol"},{"key":"1151_CR64","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/bcpt.13310","volume":"126","author":"F Hoffmann","year":"2020","unstructured":"Hoffmann F, Bantel C, Jobski K. Agranulocytosis attributed to metamizole: an analysis of spontaneous reports in EudraVigilance 1985\u20132017. Basic Clin Pharmacol Toxicol. 2020;126:116\u201325.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1151_CR65","doi-asserted-by":"crossref","unstructured":"Coxib and traditional NSAID Trialists\u2019 (CNT) Collaboration, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet Lond Engl. 2013;382:769\u201379.","DOI":"10.1016\/S0140-6736(13)60900-9"},{"key":"1151_CR66","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","volume":"17","author":"A-M Schjerning","year":"2020","unstructured":"Schjerning A-M, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17:574\u201384.","journal-title":"Nat Rev Cardiol"},{"key":"1151_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114147","volume":"180","author":"S Bindu","year":"2020","unstructured":"Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol. 2020;180:114147.","journal-title":"Biochem Pharmacol"},{"key":"1151_CR68","doi-asserted-by":"crossref","unstructured":"Derry S, Conaghan P, Da Silva JAP, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016;4:CD007400.","DOI":"10.1002\/14651858.CD007400.pub3"},{"key":"1151_CR69","doi-asserted-by":"crossref","unstructured":"Wienecke T, G\u00f8tzsche PC. Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis. Cochrane Database Syst Rev. 2004;2004:CD003789.","DOI":"10.1002\/14651858.CD003789.pub2"},{"key":"1151_CR70","doi-asserted-by":"crossref","unstructured":"Rasmussen-Barr E, Held U, Grooten WJ, Roelofs PD, Koes BW, van Tulder MW, et al. Non-steroidal anti-inflammatory drugs for sciatica. Cochrane Database Syst Rev. 2016;10:CD012382.","DOI":"10.1002\/14651858.CD012382"},{"key":"1151_CR71","doi-asserted-by":"crossref","unstructured":"Enthoven WTM, Roelofs PDDM, Deyo RA, van Tulder MW, Koes BW. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016;2:CD012087.","DOI":"10.1002\/14651858.CD012087"},{"key":"1151_CR72","doi-asserted-by":"crossref","unstructured":"van der Gaag WH, Roelofs PD, Enthoven WT, van Tulder MW, Koes BW. Non-steroidal anti-inflammatory drugs for acute low back pain. Cochrane Database Syst Rev. 2020;4:CD013581.","DOI":"10.1002\/14651858.CD013581"},{"key":"1151_CR73","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2165\/00002018-200831060-00009","volume":"31","author":"M Franceschi","year":"2008","unstructured":"Franceschi M, Scarcelli C, Niro V, Seripa D, Pazienza AM, Pepe G, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf. 2008;31:545\u201356.","journal-title":"Drug Saf"},{"key":"1151_CR74","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/pds.3592","volume":"23","author":"S Dechanont","year":"2014","unstructured":"Dechanont S, Maphanta S, Butthum B, Kongkaew C. Hospital admissions\/visits associated with drug-drug interactions: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2014;23:489\u201397.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1151_CR75","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14336\/AD.2017.0306","volume":"9","author":"S Wongrakpanich","year":"2018","unstructured":"Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9:143\u201350.","journal-title":"Aging Dis"},{"issue":"71","key":"1151_CR76","first-page":"2052","volume":"2023","author":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society","year":"2023","unstructured":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society. updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;2023(71):2052\u201381.","journal-title":"J Am Geriatr Soc"},{"key":"1151_CR77","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/cpt.1910","volume":"108","author":"E Ragni","year":"2020","unstructured":"Ragni E, Mangiavini L, Vigan\u00f2 M, Brini AT, Peretti GM, Banfi G, et al. Management of osteoarthritis during the COVID-19 pandemic. Clin Pharmacol Ther. 2020;108:719\u201329.","journal-title":"Clin Pharmacol Ther"},{"key":"1151_CR78","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217598","volume":"80","author":"A Giollo","year":"2021","unstructured":"Giollo A, Adami G, Gatti D, Idolazzi L, Rossini M. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID). Ann Rheum Dis. 2021;80: e12.","journal-title":"Ann Rheum Dis"},{"key":"1151_CR79","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/bcp.14514","volume":"87","author":"R Vaja","year":"2021","unstructured":"Vaja R, Chan JSK, Ferreira P, Harky A, Rogers LJ, Gashaw HH, et al. The COVID-19 ibuprofen controversy: a systematic review of NSAIDs in adult acute lower respiratory tract infections. Br J Clin Pharmacol. 2021;87:776\u201384.","journal-title":"Br J Clin Pharmacol"},{"key":"1151_CR80","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12889-021-10272-3","volume":"21","author":"MK Marttinen","year":"2021","unstructured":"Marttinen MK, Kautiainen H, Haanp\u00e4\u00e4 M, Pohjankoski H, Hintikka J, Kauppi MJ. Analgesic purchases among older adults\u2014a population-based study. BMC Public Health. 2021;21:256.","journal-title":"BMC Public Health"},{"key":"1151_CR81","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13:e58-68.","journal-title":"Lancet Oncol"},{"key":"1151_CR82","doi-asserted-by":"publisher","first-page":"73","DOI":"10.12998\/wjcc.v5.i3.73","volume":"5","author":"F Guerriero","year":"2017","unstructured":"Guerriero F. Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults. World J Clin Cases. 2017;5:73\u201381.","journal-title":"World J Clin Cases."},{"key":"1151_CR83","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.mayocp.2020.02.002","volume":"95","author":"HM Gazelka","year":"2020","unstructured":"Gazelka HM, Leal JC, Lapid MI, Rummans TA. Opioids in older adults: indications, prescribing, complications, and alternative therapies for primary care. Mayo Clin Proc. 2020;95:793\u2013800.","journal-title":"Mayo Clin Proc"},{"key":"1151_CR84","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jpainsymman.2019.10.022","volume":"59","author":"S Pask","year":"2020","unstructured":"Pask S, Dell\u2019Olio M, Murtagh FEM, Boland JW. The effects of opioids on cognition in older adults with cancer and chronic noncancer pain: a systematic review. J Pain Symptom Manage. 2020;59:871-893.e1.","journal-title":"J Pain Symptom Manage"},{"key":"1151_CR85","first-page":"287","volume":"8","author":"J Pergolizzi","year":"2008","unstructured":"Pergolizzi J, B\u00f6ger RH, Budd K, Dahan A, Erdine S, Hans G, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract Off J World Inst Pain. 2008;8:287\u2013313.","journal-title":"Pain Pract Off J World Inst Pain."},{"key":"1151_CR86","doi-asserted-by":"crossref","unstructured":"Zullo AR, Danko KJ, Moyo P, Adam GP, Riester M, Kimmel HJ, et al. Prevention, diagnosis, and management of opioids, opioid misuse, and opioid use disorder in older adults [Internet]. Rockville: Agency for Healthcare Research and Quality (US); 2020 [cited 2024 May 27]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564144\/","DOI":"10.23970\/AHRQEPCTB37"},{"key":"1151_CR87","doi-asserted-by":"publisher","first-page":"298","DOI":"10.15585\/mmwr.mm6911a5","volume":"69","author":"LZ Schieber","year":"2020","unstructured":"Schieber LZ, Guy GP, Seth P, Losby JL. Variation in adult outpatient opioid prescription dispensing by age and sex\u2014United States, 2008\u20132018. MMWR Morb Mortal Wkly Rep. 2020;69:298\u2013302.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1151_CR88","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/ejp.1744","volume":"25","author":"N Kr\u010devski \u0160kvar\u010d","year":"2021","unstructured":"Kr\u010devski \u0160kvar\u010d N, Morlion B, Vowles KE, Bannister K, Buchsner E, Casale R, et al. European clinical practice recommendations on opioids for chronic noncancer pain\u2014part 2: special situations. Eur J Pain Lond Engl. 2021;25:969\u201385.","journal-title":"Eur J Pain Lond Engl."},{"key":"1151_CR89","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/ejp.1736","volume":"25","author":"W H\u00e4user","year":"2021","unstructured":"H\u00e4user W, Morlion B, Vowles KE, Bannister K, Buchser E, Casale R, et al. European* clinical practice recommendations on opioids for chronic noncancer pain\u2014part 1: role of opioids in the management of chronic noncancer pain. Eur J Pain Lond Engl. 2021;25:949\u201368.","journal-title":"Eur J Pain Lond Engl."},{"key":"1151_CR90","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1097\/PTS.0000000000000566","volume":"17","author":"RD Urman","year":"2021","unstructured":"Urman RD, Seger DL, Fiskio JM, Neville BA, Harry EM, Weiner SG, et al. The burden of opioid-related adverse drug events on hospitalized previously opioid-free surgical patients. J Patient Saf. 2021;17:e76-83.","journal-title":"J Patient Saf"},{"key":"1151_CR91","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/ejp.1196","volume":"22","author":"J Faria","year":"2018","unstructured":"Faria J, Barbosa J, Moreira R, Queir\u00f3s O, Carvalho F, Dinis-Oliveira RJ. Comparative pharmacology and toxicology of tramadol and tapentadol. Eur J Pain Lond Engl. 2018;22:827\u201344.","journal-title":"Eur J Pain Lond Engl."},{"key":"1151_CR92","doi-asserted-by":"crossref","unstructured":"Toupin April K, Bisaillon J, Welch V, Maxwell LJ, J\u00fcni P, Rutjes AW, et al. Tramadol for osteoarthritis. Cochrane Database Syst Rev. 2019;5:CD005522.","DOI":"10.1002\/14651858.CD005522.pub3"},{"key":"1151_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246426","volume":"16","author":"BR Yang","year":"2021","unstructured":"Yang BR, Um H-Y, Lee MT, Kim MS, Jung S-Y. Characterizing tramadol users with potentially inappropriate co-medications: a latent class analysis among older adults. PLoS ONE. 2021;16: e0246426.","journal-title":"PLoS ONE"},{"key":"1151_CR94","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1089\/pop.2019.0220","volume":"24","author":"S Musich","year":"2021","unstructured":"Musich S, Wang SS, Schaeffer JA, Slindee L, Kraemer S, Yeh CS. Safety events associated with tramadol use among older adults with osteoarthritis. Popul Health Manag. 2021;24:122\u201332.","journal-title":"Popul Health Manag"},{"key":"1151_CR95","doi-asserted-by":"crossref","unstructured":"Wiffen PJ, Derry S, Moore RA. Tramadol with or without paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst Rev. 2017;5:CD012508.","DOI":"10.1002\/14651858.CD012508"},{"key":"1151_CR96","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162\u201373.","journal-title":"Lancet Neurol"},{"key":"1151_CR97","doi-asserted-by":"crossref","unstructured":"Cashin AG, Wand BM, O\u2019Connell NE, Lee H, Rizzo RR, Bagg MK, et al. Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2023;4:CD013815.","DOI":"10.1002\/14651858.CD013815.pub2"},{"key":"1151_CR98","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/clpt.2011.287","volume":"91","author":"KR Crews","year":"2012","unstructured":"Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD, Callaghan JT, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin Pharmacol Ther. 2012;91:321\u20136.","journal-title":"Clin Pharmacol Ther"},{"key":"1151_CR99","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00228-006-0250-8","volume":"63","author":"D Frank","year":"2007","unstructured":"Frank D, Jaehde U, Fuhr U. Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping. Eur J Clin Pharmacol. 2007;63:321\u201333.","journal-title":"Eur J Clin Pharmacol"},{"key":"1151_CR100","doi-asserted-by":"crossref","unstructured":"Hollingshead J, D\u00fchmke RM, Cornblath DR. Tramadol for neuropathic pain. Cochrane Database Syst Rev. 2006;CD003726.","DOI":"10.1002\/14651858.CD003726.pub3"},{"key":"1151_CR101","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2152\/jmi.64.311","volume":"64","author":"S Kawahito","year":"2017","unstructured":"Kawahito S, Soga T, Mita N, Satomi S, Kinoshita H, Arase T, et al. Successful treatment of mixed (mainly cancer) pain by tramadol preparations. J Med Investig JMI. 2017;64:311\u20132.","journal-title":"J Med Investig JMI."},{"key":"1151_CR102","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/SLA.0b013e3181c1cfc9","volume":"251","author":"A Brouquet","year":"2010","unstructured":"Brouquet A, Cudennec T, Benoist S, Moulias S, Beauchet A, Penna C, et al. Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery. Ann Surg. 2010;251:759\u201365.","journal-title":"Ann Surg"},{"key":"1151_CR103","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/jamainternmed.2014.6512","volume":"175","author":"J-P Fournier","year":"2015","unstructured":"Fournier J-P, Azoulay L, Yin H, Montastruc J-L, Suissa S. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. JAMA Intern Med. 2015;175:186\u201393.","journal-title":"JAMA Intern Med"},{"key":"1151_CR104","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1248\/yakushi.16-00270","volume":"137","author":"T Hosono","year":"2017","unstructured":"Hosono T, Kondo A, Kambayashi Y, Homma M. Effects of tramadol coadministration on prothrombin time-international normalized ratio in patients receiving warfarin. Yakugaku Zasshi. 2017;137:999\u20131003.","journal-title":"Yakugaku Zasshi"},{"key":"1151_CR105","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40268-023-00436-4","volume":"23","author":"YJ Lee","year":"2023","unstructured":"Lee YJ, Kim J, Han Y, Hwang K, Choi B, Oh TR, et al. Risk of hyponatremia after tramadol\/acetaminophen single-pill combination therapy: a real-world study based on the OMOP-CDM database. Drugs RD. 2023;23:289\u201396.","journal-title":"Drugs RD."},{"key":"1151_CR106","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1592\/phco.19.1.88.30515","volume":"19","author":"GE Ruoff","year":"1999","unstructured":"Ruoff GE. Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy. 1999;19:88\u201393.","journal-title":"Pharmacotherapy"},{"key":"1151_CR107","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.clinthera.2006.12.007","volume":"28","author":"R Likar","year":"2006","unstructured":"Likar R, Wittels M, Molnar M, Kager I, Ziervogel G, Sittl R. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study. Clin Ther. 2006;28:2022\u201339.","journal-title":"Clin Ther"},{"key":"1151_CR108","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s13318-022-00756-x","volume":"47","author":"AA Al-Qurain","year":"2022","unstructured":"Al-Qurain AA, Upton RN, Tadros R, Roberts MS, Wiese MD. Population pharmacokinetic model for tramadol and O-desmethyltramadol in older patients. Eur J Drug Metab Pharmacokinet. 2022;47:387\u2013402.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1151_CR109","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s40266-015-0315-4","volume":"32","author":"S Skinner-Robertson","year":"2015","unstructured":"Skinner-Robertson S, Fradette C, Bouchard S, Mouksassi M-S, Varin F. Pharmacokinetics of tramadol and O-desmethyltramadol enantiomers following administration of extended-release tablets to elderly and young subjects. Drugs Aging. 2015;32:1029\u201343.","journal-title":"Drugs Aging"},{"key":"1151_CR110","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.amjmed.2019.06.014","volume":"132","author":"MT Owsiany","year":"2019","unstructured":"Owsiany MT, Hawley CE, Triantafylidis LK, Paik JM. Opioid management in older adults with chronic kidney disease: a review. Am J Med. 2019;132:1386\u201393.","journal-title":"Am J Med"},{"key":"1151_CR111","doi-asserted-by":"crossref","unstructured":"Rosenthal NR, Silverfield JC, Wu S-C, Jordan D, Kamin M, CAPSS-105 Study Group. Tramadol\/acetaminophen combination tablets for the treatment of pain associated with osteoarthritis flare in an elderly patient population. J Am Geriatr Soc. 2004;52:374\u201380.","DOI":"10.1111\/j.1532-5415.2004.52108.x"},{"issue":"Suppl","key":"1151_CR112","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1016\/j.clinthera.2007.12.009","volume":"29","author":"G Vorsanger","year":"2007","unstructured":"Vorsanger G, Xiang J, Jordan D, Farrell J. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients. Clin Ther. 2007;29(Suppl):2520\u201335.","journal-title":"Clin Ther"},{"key":"1151_CR113","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0885-3924(01)00404-3","volume":"23","author":"JE Edwards","year":"2002","unstructured":"Edwards JE, McQuay HJ, Moore RA. Combination analgesic efficacy: individual patient data meta-analysis of single-dose oral tramadol plus acetaminophen in acute postoperative pain. J Pain Symptom Manage. 2002;23:121\u201330.","journal-title":"J Pain Symptom Manage"},{"key":"1151_CR114","first-page":"304","volume":"34","author":"GA Macheras","year":"2024","unstructured":"Macheras GA, Tzefronis D, Argyrou C, Nikolakopoulou E, G\u00e1lvez Miravete A, Karachalios TS. Pain management after total hip arthroplasty: comparative study of analgesic efficacy and tolerability between oral tramadol\/dexketoprofen and injectable paracetamol + tramadol. Hip Int J Clin Exp Res Hip Pathol Ther. 2024;34:304\u201310.","journal-title":"Hip Int J Clin Exp Res Hip Pathol Ther."},{"key":"1151_CR115","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/clpt.2008.157","volume":"85","author":"P Madadi","year":"2009","unstructured":"Madadi P, Ross CJD, Hayden MR, Carleton BC, Gaedigk A, Leeder JS, et al. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin Pharmacol Ther. 2009;85:31\u20135.","journal-title":"Clin Pharmacol Ther"},{"key":"1151_CR116","doi-asserted-by":"crossref","unstructured":"Kirchheiner J, Schmidt H, Tzvetkov M, Keulen J-THA, L\u00f6tsch J, Roots I, et al. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenom J. 2007;7:257\u201365.","DOI":"10.1038\/sj.tpj.6500406"},{"key":"1151_CR117","first-page":"28","volume":"36","author":"M Jassal","year":"2020","unstructured":"Jassal M, Egan G, Dahri K. Opioid prescribing in the elderly: a systematic review. J Pharm Technol JPT Off Publ Assoc Pharm Tech. 2020;36:28\u201340.","journal-title":"J Pharm Technol JPT Off Publ Assoc Pharm Tech."},{"key":"1151_CR118","doi-asserted-by":"publisher","first-page":"494","DOI":"10.2174\/138920010791636211","volume":"11","author":"W Leppert","year":"2010","unstructured":"Leppert W. Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain. Curr Drug Metab. 2010;11:494\u2013506.","journal-title":"Curr Drug Metab"},{"key":"1151_CR119","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.cger.2016.06.006","volume":"32","author":"JG Naples","year":"2016","unstructured":"Naples JG, Gellad WF, Hanlon JT. The role of opioid analgesics in geriatric pain management. Clin Geriatr Med. 2016;32:725\u201335.","journal-title":"Clin Geriatr Med"},{"key":"1151_CR120","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/BF03262278","volume":"29","author":"AL van Ojik","year":"2012","unstructured":"van Ojik AL, Jansen PAF, Brouwers JRBJ, van Roon EN. Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids. Drugs Aging. 2012;29:615\u201325.","journal-title":"Drugs Aging"},{"key":"1151_CR121","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jgo.2019.03.012","volume":"10","author":"MDL Alarc\u00f3n","year":"2019","unstructured":"Alarc\u00f3n MDL, Est\u00e9vez FV, Cabez\u00f3n-Guti\u00e9rrez L, Padr\u00f3s MC, Mart\u00edn-Arroyo JMT, Rebollo MA, et al. Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study. J Geriatr Oncol. 2019;10:643\u201352.","journal-title":"J Geriatr Oncol."},{"key":"1151_CR122","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40122-019-00143-6","volume":"9","author":"J Gudin","year":"2020","unstructured":"Gudin J, Fudin J. A narrative pharmacological review of buprenorphine: a unique opioid for the treatment of chronic pain. Pain Ther. 2020;9:41\u201354.","journal-title":"Pain Ther"},{"key":"1151_CR123","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/bja\/ael051","volume":"96","author":"A Dahan","year":"2006","unstructured":"Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E, et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth. 2006;96:627\u201332.","journal-title":"Br J Anaesth"},{"key":"1151_CR124","first-page":"714","volume":"21","author":"L Webster","year":"2020","unstructured":"Webster L, Gudin J, Raffa RB, Kuchera J, Rauck R, Fudin J, et al. Understanding buprenorphine for use in chronic pain: expert opinion. Pain Med Malden Mass. 2020;21:714\u201323.","journal-title":"Pain Med Malden Mass."},{"key":"1151_CR125","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2147\/JPR.S305146","volume":"14","author":"M Hale","year":"2021","unstructured":"Hale M, Garofoli M, Raffa RB. Benefit-risk analysis of buprenorphine for pain management. J Pain Res. 2021;14:1359\u201369.","journal-title":"J Pain Res"},{"key":"1151_CR126","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1016\/j.jpainsymman.2023.06.022","volume":"66","author":"M Chwistek","year":"2023","unstructured":"Chwistek M, Sherry D, Kinczewski L, Silveira MJ, Davis M. Should buprenorphine be considered a first-line opioid for the treatment of moderate to severe cancer pain? J Pain Symptom Manage. 2023;66:e638\u201343.","journal-title":"J Pain Symptom Manage"},{"key":"1151_CR127","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41581-021-00484-6","volume":"18","author":"DG Tobin","year":"2022","unstructured":"Tobin DG, Lockwood MB, Kimmel PL, Dember LM, Eneanya ND, Jhamb M, et al. Opioids for chronic pain management in patients with dialysis-dependent kidney failure. Nat Rev Nephrol. 2022;18:113\u201328.","journal-title":"Nat Rev Nephrol"},{"key":"1151_CR128","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2796.2006.01667.x","volume":"260","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med. 2006;260:76\u201387.","journal-title":"J Intern Med"},{"key":"1151_CR129","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10198-015-0673-1","volume":"17","author":"A Hirst","year":"2016","unstructured":"Hirst A, Knight C, Hirst M, Dunlop W, Akehurst R. Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine. Eur J Health Econ HEPAC Health Econ Prev Care. 2016;17:217\u201327.","journal-title":"Eur J Health Econ HEPAC Health Econ Prev Care."},{"key":"1151_CR130","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","volume":"19","author":"EF McCance-Katz","year":"2010","unstructured":"McCance-Katz EF, Sullivan LE, Nallani S. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review. Am J Addict. 2010;19:4\u201316.","journal-title":"Am J Addict"},{"key":"1151_CR131","first-page":"401","volume":"27","author":"M Behzadi","year":"2018","unstructured":"Behzadi M, Joukar S, Beik A. Opioids and cardiac arrhythmia: a literature review. Med Princ Pract Int J Kuwait Univ Health Sci Cent. 2018;27:401\u201314.","journal-title":"Med Princ Pract Int J Kuwait Univ Health Sci Cent."},{"key":"1151_CR132","doi-asserted-by":"publisher","first-page":"393","DOI":"10.5055\/jom.2015.0289","volume":"11","author":"DM Biondi","year":"2015","unstructured":"Biondi DM, Xiang J, Etropolski M, Moskovitz B. Tolerability and efficacy of tapentadol extended release in elderly patients \u2265 75 years of age with chronic osteoarthritis knee or low back pain. J Opioid Manag. 2015;11:393\u2013403.","journal-title":"J Opioid Manag"},{"key":"1151_CR133","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1080\/03007995.2018.1520085","volume":"34","author":"B Lange","year":"2018","unstructured":"Lange B, Sohns M, Tempero J, Elling C. Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials. Curr Med Res Opin. 2018;34:2113\u201323.","journal-title":"Curr Med Res Opin"},{"key":"1151_CR134","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40266-015-0268-7","volume":"32","author":"FC Veal","year":"2015","unstructured":"Veal FC, Peterson GM. Pain in the frail or elderly patient: does tapentadol have a role? Drugs Aging. 2015;32:419\u201326.","journal-title":"Drugs Aging"},{"key":"1151_CR135","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s40265-021-01515-z","volume":"81","author":"L Roulet","year":"2021","unstructured":"Roulet L, Rollason V, Desmeules J, Piguet V. Tapentadol versus tramadol: a narrative and comparative review of their pharmacological, efficacy and safety profiles in adult patients. Drugs. 2021;81:1257\u201372.","journal-title":"Drugs"},{"key":"1151_CR136","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12873-022-00592-x","volume":"22","author":"K Ji","year":"2022","unstructured":"Ji K, Gong X, Luan T, Gao X, Zang B. Pain management of nalbuphine and sufentanil in patients admitted intensive care unit of different ages. BMC Emerg Med. 2022;22:50.","journal-title":"BMC Emerg Med"},{"key":"1151_CR137","unstructured":"Larsen D, Maani CV. Nalbuphine. StatPearls Internet [Internet]. StatPearls Publishing; 2023 [cited 2024 May 28]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534283\/"},{"key":"1151_CR138","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/MCG.0000000000001801","volume":"57","author":"J Horrigan","year":"2023","unstructured":"Horrigan J, Bhumi S, Miller D, Jafri M, Tadros M. Management of opioid-induced constipation in older adults. J Clin Gastroenterol. 2023;57:39\u201347.","journal-title":"J Clin Gastroenterol"},{"key":"1151_CR139","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1532-5415.2011.03318.x","volume":"59","author":"M Miller","year":"2011","unstructured":"Miller M, St\u00fcrmer T, Azrael D, Levin R, Solomon DH. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc. 2011;59:430\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"1151_CR140","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/jgs.12148","volume":"61","author":"L Rolita","year":"2013","unstructured":"Rolita L, Spegman A, Tang X, Cronstein BN. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc. 2013;61:335\u201340.","journal-title":"J Am Geriatr Soc"},{"key":"1151_CR141","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.2147\/DDDT.S86983","volume":"9","author":"A Kotlinska-Lemieszek","year":"2015","unstructured":"Kotlinska-Lemieszek A, Klepstad P, Haugen DF. Clinically significant drug-drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review. Drug Des Devel Ther. 2015;9:5255\u201367.","journal-title":"Drug Des Devel Ther."},{"key":"1151_CR142","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.neurol.2020.01.361","volume":"176","author":"X Moisset","year":"2020","unstructured":"Moisset X, Bouhassira D, Avez Couturier J, Alchaar H, Conradi S, Delmotte MH, et al. Pharmacological and non-pharmacological treatments for neuropathic pain: systematic review and French recommendations. Rev Neurol (Paris). 2020;176:325\u201352.","journal-title":"Rev Neurol (Paris)."},{"key":"1151_CR143","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.2147\/JPR.S138099","volume":"10","author":"JV Holbech","year":"2017","unstructured":"Holbech JV, Jung A, Jonsson T, Wanning M, Bredahl C, Bach FW. Combination treatment of neuropathic pain: Danish expert recommendations based on a Delphi process. J Pain Res. 2017;10:1467\u201375.","journal-title":"J Pain Res"},{"key":"1151_CR144","doi-asserted-by":"crossref","unstructured":"Wilczy\u0144ski K, Mazurski A, Kotucha K. Antidepressant efficacy in managing nonspecific chronic lower back pain among older adults: a review. J Pain Palliat Care Pharmacother. 2024;1\u201315.","DOI":"10.1080\/15360288.2024.2384961"},{"key":"1151_CR145","doi-asserted-by":"crossref","unstructured":"Wei Y-JJ, Winterstein AG, Schmidt S, Fillingim RB, Daniels MJ, DeKosky ST, et al. Clinical and adverse outcomes associated with concomitant use of CYP2D6-metabolized opioids with antidepressants in older nursing home residents\u202f: a target trial emulation study. Ann Intern Med. 2024;177:1058\u201368.","DOI":"10.7326\/M23-3109"},{"key":"1151_CR146","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40266-014-0202-4","volume":"31","author":"G Pickering","year":"2014","unstructured":"Pickering G. Antiepileptics for post-herpetic neuralgia in the elderly: current and future prospects. Drugs Aging. 2014;31:653\u201360.","journal-title":"Drugs Aging"},{"key":"1151_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2024.107382","volume":"203","author":"MH Porwal","year":"2024","unstructured":"Porwal MH, Razzak AN, Kumar V, Obeidat AZ, Sharma U. An analysis of suicidal and self-injurious behavior reports with antiseizure medications in the FDA adverse event database. Epilepsy Res. 2024;203: 107382.","journal-title":"Epilepsy Res"},{"key":"1151_CR148","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","volume":"85","author":"RH Dworkin","year":"2010","unstructured":"Dworkin RH, O\u2019Connor AB, Audette J, Baron R, Gourlay GK, Haanp\u00e4\u00e4 ML, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85:S3-14.","journal-title":"Mayo Clin Proc"},{"key":"1151_CR149","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1097\/j.pain.0000000000001502","volume":"160","author":"G Pickering","year":"2019","unstructured":"Pickering G, Voute M, Macian N, Ganry H, Pereira B. Effectiveness and safety of 5% lidocaine-medicated plaster on localized neuropathic pain after knee surgery: a randomized, double-blind controlled trial. Pain. 2019;160:1186\u201395.","journal-title":"Pain"},{"key":"1151_CR150","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40266-019-00739-9","volume":"37","author":"G Pickering","year":"2020","unstructured":"Pickering G, Lucchini C. Topical treatment of localized neuropathic pain in the elderly. Drugs Aging. 2020;37:83\u20139.","journal-title":"Drugs Aging"},{"key":"1151_CR151","doi-asserted-by":"crossref","unstructured":"Derry S, Rice AS, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;1:CD007393.","DOI":"10.1002\/14651858.CD007393.pub4"},{"key":"1151_CR152","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2147\/JPR.S435809","volume":"17","author":"G Pickering","year":"2024","unstructured":"Pickering G, Engelen S, Stupar M, Ganry H, Eerdekens M. Is the capsaicin 179 mg (8% w\/w) cutaneous patch an appropriate treatment option for older patients with peripheral neuropathic pain? J Pain Res. 2024;17:1327\u201344.","journal-title":"J Pain Res"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01151-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-024-01151-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01151-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T16:37:42Z","timestamp":1733935062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-024-01151-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,27]]},"references-count":152,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1151"],"URL":"https:\/\/doi.org\/10.1007\/s40266-024-01151-8","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,27]]},"assertion":[{"value":"16 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pickering Gis\u00e8le (GP), Kotli\u0144ska-Lemieszek Aleksandra (AK), Krcevski Skvarc Nevenka (NK), O\u2019Mahony Denis (DO), Monacelli Fiammetta (FM), Knaggs Roger (RK), Morel V\u00e9ronique (VM), Kocot-K\u0119pska Magdalena (MK) have no conflicts of interest related to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"GP, AK, NK, DO, FM,RK, VM, MK all contributed equally to the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"No funding to report for the preparation of the paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent (participation and publication)"}},{"value":"Data sharing not applicable to this article as no datasets were generated or analysed during the current study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}